The experimental coronavirus treatment remdesivir has failed in its first randomized clinical trial, inadvertently released results showed on Thursday, dampening expectations for the closely watched drug.
A draft summary went online briefly on the WHO Web site and was first reported by the Financial Times and health news Web site Stat, which posted a screenshot.
However, Gilead Sciences, the company behind the medicine, disputed how the now-deleted post had characterized the findings, saying that the data showed a “potential benefit.”
Photo: AFP
The Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group, the summary said, adding that remdesivir was stopped early in 18 patients because of side effects.
The authors said that remdesivir was “not associated with a difference in time to clinical improvement” compared with the control.
After a month, 13.9 percent of the patients on remdesivir had died, compared with 12.8 percent of those in the control group. The difference is not statistically significant.
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.
“We believe the post included inappropriate characterizations of the study,” a Gilead spokesman told reporters, adding that it was terminated early due to low enrollment and was therefore not statistically meaningful.
“As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease,” the spokesman said.
The study does not represent the final word on the matter, and there are several large-scale trials in advanced stages that should soon provide a clearer picture.
Remdesivir, which is administered intravenously, was among the first drugs suggested as a treatment for the novel coronavirus and as such has great hopes riding on it.
Last week, Stat reported that it had shown significant efficacy at a Chicago hospital where patients who are part of one of the major trials are being treated.
The US National Institutes of Health also reported it that had proven effective in a small experiment on monkeys.
Remdesivir, which previously failed in trials against Ebola, belongs to a class of drugs that act on the virus directly — as opposed to controlling the abnormal and often lethal autoimmune response it causes. It mimics one of the four building blocks of RNA and DNA, and gets absorbed into the virus’ genome, which in turn stops the pathogen from replicating.
Anti-malarial drugs hydroxychloroquine and chloroquine have also been widely used on COVID-19 on a so-called “compassionate basis” pending results from large trials, with early studies decidedly mixed.
Other therapies that are being studied include collecting antibodies from COVID-19 survivors and injecting them in patients, or harvesting antibodies from genetically engineered mice that were deliberately infected.
Separately in France, new research shows that nicotine could protect people from contracting COVID-19.
The findings came after researchers at a top Paris hospital examined 343 COVID-19 patients, as well as 139 people with the illness who had milder symptoms.
They found that a low number of them smoked, compared with smoking rates of about 35 percent in France’s general population.
“Among these patients, only 5 percent were smokers,” said Zahir Amoura, the study’s coauthor and a professor of internal medicine.
The research echoed similar findings published in the New England Journal of Medicine last month suggesting that 12.6 percent of 1,000 people infected in China were smokers.
That was a much lower figure than the number of regular smokers in China’s general population, about 26 percent, WHO data showed.
The theory is that nicotine could adhere to cell receptors, therefore blocking the novel coronavirus from entering cells and spreading in the body, said neurobiologist Jean-Pierre Changeux from France’s Pasteur Institute, who also coauthored the study.
The researchers are awaiting approval from health authorities to carry out further clinical trials.
The researchers are looking into whether nicotine could help to prevent “cytokine storms,” a rapid overreaction of the immune system that scientists think could play a key role in fatal COVID-19 cases.
However, with further research needed, experts are not encouraging people to pick up smoking or use nicotine patches as a protective measure against the virus.
“We must not forget the harmful effects of nicotine,” French Director-General for Health Jerome Salomon said.
“Those who do not smoke should absolutely not use nicotine substitutes,” which cause side effects and addiction, he said.
PHISHING: The con might appear convincing, as the scam e-mails can coincide with genuine messages from Apple saying you have run out of storage For a while you have been getting messages from Apple saying “your iCloud storage is full.” They say you have exceeded your storage plan, so documents are no longer being backed up, and photos you take are not being uploaded. You have been resisting Apple’s efforts to get you to pay a minimum of ￡0.99 (US$1.33) a month for more storage, but it seems that you cannot keep putting off the inevitable: You have received an e-mail which says your iCloud account has been blocked, and your photos and videos would be deleted very soon. To keep them you need
For two decades, researchers observed members of the Ngogo chimpanzee group of Kibale National Park in Uganda spend their days eating fruits and leaves, resting, traveling and grooming in their tropical rainforest abode, but this stable community then fractured and descended into years of deadly violence. The researchers are now describing the first clearly documented example of a group of wild chimpanzees splitting into two separate factions, with one launching a series of coordinated attacks against the other. Adult males and infants were targeted, with 28 deaths. “Biting, pounding the victim with their hands, dragging them, kicking them — mostly adult males,
The Israeli military has demolished entire villages as part of its invasion of south Lebanon, rigging homes with explosives and razing them to the ground in massive remote detonations. The Guardian reviewed three videos posted by the Israeli military and on social media, which showed Israel carrying out mass detonations in the villages of Taybeh, Naqoura and Deir Seryan along the Israel-Lebanon border. Lebanese media has reported more mass detonations in other border villages, but satellite imagery was not readily available to verify these claims. The demolitions came after Israeli Minister of Defense Israel Katz called for the destruction of
SUPERFAN: The Japanese PM played keyboard in a Deep Purple tribute band in middle school and then switched to drums at university, she told the British rock band Legendary British rock band Deep Purple yesterday made Japanese Prime Minister Sanae Takaichi’s day with a brief visit to their high-profile superfan as they returned to the nation they first toured more than half a century ago. Takaichi’s reputation as an amateur drummer, and a fan of hard rock and heavy metal has been well documented, and she has referred to Deep Purple as one of her favorite bands along with the likes of Black Sabbath and Iron Maiden. “You are my god,” a giddy Takaichi said in English to Deep Purple drummer Ian Paice, presenting him with a set of made-in-Japan
RSS